| Edwin Yoshio Endo | |
|
98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 | |
| (808) 487-5500 | |
| Not Available |
| Full Name | Edwin Yoshio Endo |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 98-1247 Kaahumanu St, Aiea, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538464011 | NPI | - | NPPES |
| 04604501 | Medicaid | HI | |
| HEENDO | Other | HI | MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 149 (Hawaii) | Primary |
| Provider Name | Edwin Y Endo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861471674 PECOS PAC ID: 9830288372 Enrollment ID: I20071205000499 |
News Archive
Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.
A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.
Researchers in a multicenter international study have identified a new gene that, if mutated, may increase a woman's risk of breast cancer by more than a third.
› Verified 2 days ago
| Provider Name | Edwin Yoshio Endo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073975843 PECOS PAC ID: 6103111836 Enrollment ID: I20160819001655 |
News Archive
Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.
A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.
Researchers in a multicenter international study have identified a new gene that, if mutated, may increase a woman's risk of breast cancer by more than a third.
› Verified 2 days ago
| Provider Name | Nicole Yokoyama |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255992996 PECOS PAC ID: 3476880451 Enrollment ID: I20190814000882 |
News Archive
Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.
A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.
Researchers in a multicenter international study have identified a new gene that, if mutated, may increase a woman's risk of breast cancer by more than a third.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edwin Yoshio Endo 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 Ph: (808) 487-5500 | Edwin Yoshio Endo 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 Ph: (808) 487-5500 |
News Archive
Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.
A team of researchers visited 64 pubs across the north west of England. They measured air quality using a portable monitor for at least 30 minutes in an area of the pub where smoking was allowed.
Researchers in a multicenter international study have identified a new gene that, if mutated, may increase a woman's risk of breast cancer by more than a third.
› Verified 2 days ago
Styleyes Optometrist Medicare: Medicare Enrolled Practice Location: 98-150 Kaonohi St, B211, Aiea, HI 96701 Phone: 808-486-3937 Fax: 808-486-3386 | |
Dr. Melanie Keiko Nakashima, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-486-2694 | |
Dr. Walter M Yamamoto, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-205 Moanalua Rd, Ste 210, Aiea, HI 96701 Phone: 808-487-1010 Fax: 808-488-3433 | |
Mr. Edwin Yoshio Endo Ii, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 98-1247 Kaahumanu St, Suite 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-488-2322 | |
Isaac J. Kaopua Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 98-1247 Kaahumanu St, Suite #116, Aiea, HI 96701 Phone: 808-488-4000 Fax: 808-488-7667 | |
Dr. Walter Gwok Wo Au, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St Ste 105, Aiea, HI 96701 Phone: 808-487-5500 | |
Marissa Matsuyama, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-128 Aiea Heights Dr Ste 703, Aiea, HI 96701 Phone: 808-487-7938 |